Novartis looks at offloading its generic pills business in U.S. as market continues to decline
admin 4th December 2017 Uncategorised 0The market for generic pills has gotten so bad in the U.S. that Novartis is thinking about selling off its oral solids business there, outgoing CEO Joseph Jimenez told analysts.
More: Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Source: fierce